Bradley Thomas, MD
Vascular Surgery · Louisville, KYNPI 1104933720
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,075 of the $3,944 with a category attached, or 78.0%. 22 manufacturers reported payments, led by Zimmer Biomet at 24.4% of the total. That places this record below the midpoint for vascular surgery clinicians in KY, where the typical reported total is $9,151.
Across 81 payments — averaging $48.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$963
- W. L. Gore & Associates, Inc.$641
- Boston Scientific$630
- Silk Road Medical, Inc.$379
- Penumbra, Inc.$289
- Integra Lifesciences Corporation$172
- plus $870 from 16 others
Across 13 payments — averaging $770.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cook Research Incorporated$4K
- W. L. Gore & Associates, Inc.$4K
- Silk Road Medical, Inc.$2K
What the payments were for
- Travel & lodging$69218%
- Food & beverage$3,07578%
- Education$180%
- Other$1594%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 7 | $963 |
| W. L. Gore & Associates, Inc. | 12 | $641 |
| Boston Scientific | 29 | $630 |
| Silk Road Medical, Inc. | 3 | $379 |
| Penumbra, Inc. | 2 | $289 |
| Integra Lifesciences Corporation | 2 | $172 |
| Terumo Medical Corporation | 4 | $168 |
| Bolton Medical Inc | 1 | $155 |
| Sanara Medtech Inc. | 1 | $142 |
| Cvrx, Inc. | 1 | $69 |
| Pfizer | 3 | $53 |
| Siemens Medical Solutions USA, Inc. | 3 | $52 |
| Cook Medical LLC | 3 | $50 |
| Bone Support Inc. | 1 | $46 |
| Smith+Nephew | 2 | $30 |
| Johnson & Johnson | 1 | $18 |
| Inari Medical, Inc. | 1 | $18 |
| Atricure, Inc. | 1 | $16 |
| EKOS Corporation | 1 | $15 |
| Polynovo North America LLC | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Philips North America LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Thoracic Reconstruction$624
- ENROUTE Transcarotid Neuroprotection System$379
- Indigo System$289
- ENHANCE Transcarotid Peripheral Access Kit$259
- RIBFIX BLU ADVANTAGE$257
- ENROUTE Transcarotid Stent$255
- CYTAL$159
- TREO ABDOMINAL STENT-GRAFT SYSTEM$155
- CellerateRx$142
- GORE VIABAHN VBX Balloon Expandable Endo$138
- ENROUTE .014 Guidewire$136
- VIABAHN Endoprosthesis with Heparin Bioactive Surface$128
- ENROUTE Transcarotid Stent System$123
- ENROUTE 0.014 Guidewire$123
- VIABAHN VBX Balloon Expandable Endoprosthesis$123
- GENERAL VASCULAR INTERVENTION$117
How this compares
$3,944 in reported general payments places this provider in the 25th percentile of 72 vascular surgery providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $12,610 |
| ClopidogrelClopidogrel Bisulfate | 108 | $1,110 |
| Cilostazol | 76 | $699 |
| Atorvastatin Calcium | 86 | $421 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $73 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $53 | $12,61017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 72 vascular surgery providers in Kentucky.
Other vascular surgery in Louisville
- Amit DwivediLouisville$406K
- Abindra SigdelLouisville$84K
- Ferenc NagyLouisville$47K
- Gregory SchmiederLouisville$44K
- Erik WayneLouisville$25K
- Matthew JungLouisville$24K
- Nancy ClarkLouisville$19K
- Ashlee VinyardLouisville$12K
- Salem GeorgeLouisville$10K
- Nathaniel LiuLouisville$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.